1. Home
  2. CLYM vs BLFY Comparison

CLYM vs BLFY Comparison

Compare CLYM & BLFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLYM
  • BLFY
  • Stock Information
  • Founded
  • CLYM 2018
  • BLFY 1939
  • Country
  • CLYM United States
  • BLFY United States
  • Employees
  • CLYM N/A
  • BLFY N/A
  • Industry
  • CLYM
  • BLFY Commercial Banks
  • Sector
  • CLYM
  • BLFY Finance
  • Exchange
  • CLYM NYSE
  • BLFY Nasdaq
  • Market Cap
  • CLYM 201.7M
  • BLFY 213.4M
  • IPO Year
  • CLYM 2021
  • BLFY N/A
  • Fundamental
  • Price
  • CLYM $1.82
  • BLFY $9.44
  • Analyst Decision
  • CLYM
  • BLFY Hold
  • Analyst Count
  • CLYM 0
  • BLFY 2
  • Target Price
  • CLYM N/A
  • BLFY $11.50
  • AVG Volume (30 Days)
  • CLYM 668.0K
  • BLFY 54.2K
  • Earning Date
  • CLYM 11-12-2024
  • BLFY 01-29-2025
  • Dividend Yield
  • CLYM N/A
  • BLFY N/A
  • EPS Growth
  • CLYM N/A
  • BLFY N/A
  • EPS
  • CLYM N/A
  • BLFY N/A
  • Revenue
  • CLYM N/A
  • BLFY $40,112,000.00
  • Revenue This Year
  • CLYM N/A
  • BLFY N/A
  • Revenue Next Year
  • CLYM N/A
  • BLFY $16.10
  • P/E Ratio
  • CLYM N/A
  • BLFY N/A
  • Revenue Growth
  • CLYM N/A
  • BLFY N/A
  • 52 Week Low
  • CLYM $1.73
  • BLFY $7.90
  • 52 Week High
  • CLYM $11.55
  • BLFY $11.48
  • Technical
  • Relative Strength Index (RSI)
  • CLYM N/A
  • BLFY 45.11
  • Support Level
  • CLYM N/A
  • BLFY $9.18
  • Resistance Level
  • CLYM N/A
  • BLFY $9.52
  • Average True Range (ATR)
  • CLYM 0.00
  • BLFY 0.28
  • MACD
  • CLYM 0.00
  • BLFY 0.05
  • Stochastic Oscillator
  • CLYM 0.00
  • BLFY 65.57

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

Share on Social Networks: